06Sep 2023
DCGI Releases Safety Advisory on Digene Gel Following Abbott's Voluntary Recall

DCGI Releases Safety Advisory on Digene Gel Following Abbott's Voluntary Recall

The Drugs Controller General of India has issued an advisory concerning the popular antacid Digene gel. This move comes in response to safety concerns arising from a voluntary recall initiated by drugmaker Abbott. Healthcare professionals are urged to discontinue prescribing this product and to inform patients accordingly. The drug regulator also encourages reporting any adverse drug reactions linked to its usage. State drug controllers are requested to monitor the market and take necessary actions. In response to isolated customer complaints regarding taste and odor, Abbott India has voluntarily recalled Digene Gel antacid medicine manufactured at its Goa site.

  • #family health

Like

Save

Share